Condition: CKD (Chronic Kidney Disease) Stage 5D · Sponsor: Guangdong Provincial People's Hospital
People with kidney failure requiring dialysis have a much higher risk of developing cardiovascular (CV) disease compared with the general population. A cardiac cause accounts for 58% of all deaths in patients with end stage kidney disease (ESKD). At the same time, this population has increased risks of clotting as well as bleeding episodes. While aspirin is known to reduce cardiovascular complications in the general population, evidence to support the use of aspirin in people with ESKD receiving dialysis therapy is currently lacking. The ASPIrin to Reduce Event in Dialysis (ASPIRED) trial will test whether aspirin use in dialysis patients safely improves outcomes compared with no aspirin use.
This description comes directly from the study's public registry record.
Xueqing Yu · +86-20-83827812 · yuxueqing@gdph.org.cn
Li Fan · +86-20-87755766-8174 · fanli@gdph.org.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Fujian Medical University | Fuzhou, Fujian, China | Recruiting |
| Shanghang County Hospital | Longyan, Fujian, China | Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Recruiting |
| Dongguan Donghua Hospital | Dongguan, Guangdong, China | Recruiting |
| Dongguan Hospital of Integrative Traditional Chinese and Western Medicine | Dongguan, Guangdong, China | Not Yet Recruiting |
| Dongguan Houjie Hospital | Dongguan, Guangdong, China | Not Yet Recruiting |
| Dongguan Eighth People's Hospital | Dongguan, Guangdong, China | Recruiting |
| Dongguan Marina Bay Center Hospital | Dongguan, Guangdong, China | Recruiting |
| Dongguan People's Hospital | Dongguan, Guangdong, China | Recruiting |
| Dongguan Songshan Lake Center Hospital | Dongguan, Guangdong, China | Withdrawn |
| Lufeng People's Hospital | Donghai, Guangdong, China | Withdrawn |
| Foshan Gaoming District People's Hospital | Foshan, Guangdong, China | Recruiting |
+ 127 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04381143